Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.

The agreement covers comprehensive federal oversight services.
Callan JMB Inc. and Attune Biotech Inc. announced on January 15, 2026 Callan JMB Inc. has signed a strategic teaming agreement with Attune Biotech Inc. to provide comprehensive federal oversight services for Attune's manufacturing, quality assurance, and deployment operations.
The announcement cited $50 to $75 million, and $25 million to $45 million.
CALLAN JMB INC. has a free float of 1,376,700 shares and 4,481,100 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.